Recent highlights include:

• The Crisis in U.S. Cancer Care: Law, Privatization, and Profit, 110 Minnesota Law Review(forthcoming 2026). Link.
• The Deregulation of Cancer, Texas A&M Law Review (forthcoming 2026).Link.
• Loper Bright’s Deregulatory Synergies, 55 Seton Hall Law Review 1697 (symposium piece, 2025) (with Renee Farmer).Link.
• Presidential Powers for LGBTQI+ Equity: Advances and Rollbacks,Health Affairs Forefront (2025) (with Gilbert Gonzales, Kyle Gavulic, and Carson Ferrara). Link.
• A New Legal Standard for Medical Malpractice,JAMA (2025) (with Christopher Robertson, Louise Perkins King, and Bill Sage). Link.
• E-Cigarettes at the Supreme Court — Potential Implications for the FDA and Public Health, 392New England Journal of Medicine 417 (2025) (with Christopher Robertson). Link.
• The Future of Gender-Affirming Care — A Law and Policy Perspective on the Cass Review, 392New England Journal of Medicine 526 (2025) (with Craig Konnoth). Link.
• FDA’s New Rule for Regulating Laboratory-Developed Tests, 5JAMA Health Forum e242917 (2024) (with I. Glenn Cohen and Eli Y. Adashi).  Link.
• Legal Accountability for Health Crises: “Unshielding” the Sackler Family, 332 JAMA 1515 (2024) (with Adam Levitin and Michael S. Sinha).Link.
• Contesting Deregulation and Medicalization to Revitalize Public Health, 114American Journal of Public Health 968 (2024). Link.
• The Biden Administration’s Push to Lower Drug Prices Through March-In Rights, 332 JAMA 449 (2024) (with Jonas Anderson).Link.
• Medicare Advantage Under Fire: Public Criticism and Implications, 39Journal of General Internal Medicine 2849 (2024) (with I. Glenn Cohen and Eli Y. Adashi). Link.
• Firearm Policy in the Hospital Setting—Recognizing Health Care as a “Sensitive Place”,332 JAMA 658 (2024) (with Joseph Blocher, Richard Saver, and Joshua Romero). Link.
• State and Local Climate Litigation for Protecting Public Health, 390New England Journal of Medicine 2231 (2024) (with Avery Emery). Link.
• Immunity Through Bankruptcy for the Sackler Family, 126 WEST VIRGINIA LAW REVIEW 823 (symposium piece, 2024) (with Michael S. Sinha). Link.
• The Fall of FDA Review, 22 YALE JOURNAL OF HEALTH POLICY, LAW, AND ETHICS 95 (2023) (peer-reviewed). Link.
• Opioid Accountability, 89 TENNESSEE LAW REVIEW 611 (2022). Link.
• Public Health in the Opioid Litigation, 53 LOYOLA UNIVERSITY CHICAGO LAW JOURNAL 11 (2021). Link.
• Tobacco Reborn: The Rise of E-Cigarettes and Regulatory Approaches, 25 LEWIS & CLARK LAW REVIEW 827 (2021). Link.
• Constitutional Cohesion and the Right to Public Health, 53 MICHIGAN JOURNAL OF LAW REFORM 173 (2019) (with James G. Hodge & others). Link.

SSRN Profile

 

Media:

• May 1, 2025 – Henry Carnell, Mother Jones – New HHS report on transgender health care.
• February 18, 2025 – Grady McGregor, The Wire China – E-Cigarettes, the Supreme Court, and Chinese Imports.
• February 13, 2025 – Mark Payne, Law360 – Informed Consent in Transgender Health Care.
• January 16, 2025 – Stephen Morrissey, New England Journal of Medicine, NEJM Interviews – E-Cigarettes and FDA Authority at the Supreme Court.Link.
• January 14, 2025 – Jen Christensen, CNN – The Cass Review, Gender-Affirming Care, and the Law.
• November 26, 2024 – Marc Novicoff, Politico – The Continued Sale of Illicit E-Cigarettes in the U.S.Link.
• November 25, 2024 – John Kruzel, Reuters – E-Cigarettes at the Supreme Court.Link.
• November 11, 2024 – Theresa Schliep, Law360 – CDC’s and FDA’s Vulnerability to Political Interference
• October 29, 2024 – Jeanne Lenzer, The Atlantic – FDA Regulation of Lecanemab (Leqembi) and Adverse Events.
• October 29, 2024 – Elaine Chen, STAT News – FDA Regulation of Lecanemab (Leqembi) and Adverse Events.
• October 17, 2024 – Christina Jewett, New York Times – Medical Device Adverse Event Reporting and Conflicts of Interest at the FDA.

 

Outreach/Service:

• May 1–3, 2025 – Hosted and co-organized the Regulation and Innovation in the Biosciences (RIBS) workshop at the S.J. Quinney College of Law, University of Utah.
• September 3, 2024 – Participated in preparation of amicus brief,Brief of Professors of Law, Medicine, and Public Health as Amici Curiae in Support of Petitioner, U.S. Supreme Court, S. v. Skrmetti.